Cardurion

Cardurion, a biopharmaceutical company based in Burlington, MA, is transforming the treatment of cardiovascular disease. With approximately 11 employees, Cardurion is addressing unmet needs through groundbreaking clinical programs in PDE9 and CaMKII inhibition, leveraging its expertise in cardiovascular signaling pathways and a strategic portfolio approach driven by its in-house drug discovery group.